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eywords: 
 Amebiasis is one of the gastrointestinal tract infection disease caused by Entamoeba 
histolytica, a parasitic protozoan. Amebiasis is the second disease, caused by 
parasite, that leading cause of death after malaria. Infection occurs through faecal-
oral route and after ingestion a contaminated food and beverages by human faeces. 
The pathogenesis of E. histolytica can be classified into 3 processes, i.e: death of host 
cell, inflammation, and parasitic invasion. The recent years, a molecularly amebiasis 
pathogenesis has been developed, i.e: adherence, phagocytosis, tropogocytosis of 
host cell and how the parasites can survive and attack host cells so it can cause an 
infection in humans. Molecular development is an important thing to be considered 
in the selection of amebiasis therapy.  
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INTRODUCTION 
Amebiasis is one of the gastrointestinal tract 
infections caused by Entamoeba histolytica which 
is an unicellular and anaerob microorganism(1,2). 
About 80-90% of infections have no symptoms and 
self-limiting(3,4) and 10-20% can cause severe 
infections, amebic liver abscess and amebic 
colitis(4,5). Amebic colitis, the major cause of severe 
diarrhea at the world and registered in 15 causes of 
diarrhea at children aged 2 years living in 
developing countries(4). Diarrhea is the number two 
cause of death in children under 5 years and kills 
around 525,000 children every year(6). Based on 
RISKESDAS (2007), the prevalence of diarrhea in 
Indonesia is 9.0% with a range of 4.2-18.9%, the 
highest prevalence in the Province of Nanggroe 
Aceh Darussalam and the lowest in the Province of 
DI Yogyakarta(7). 
Progress in molecular methodology 
increases our knowledge regarding the differences 
in E. histolytica with other non-pathogenic 
Entamoeba species such as E. dispar and E. 
Bangladeshi(4). In the last few years the 
pathogenesis of amebiasis is molecularly 
developed. Likewise, the mechanism for avoiding 
immune responses can increase our knowledge 
regarding amebiasis and can help in the selection 
of amebiasis therapy. 
 
AMEBIASIS 
Epidemiology 
Amebiasis is found throughout the world 
with the greatest prevalence in developing 
countries, mainly in tropical and subtropical 
regions, specifically Asia, Africa, Indonesia, India, 
Mexico, South Africa, and South America. 
Optimal climate conditions in the zone that make 
protozoan cysts can last for several days in the 
external environment (1,2,4).  
Entamoeba histolytica is the number two 
cause of death caused by parasites in humans after 
malaria. Globally, around 50 million people have 
infections, with greater than 100,000 deaths each 
year reported due to amebiasis. The source of 
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infection is from swallowing water or food 
contaminated with faeces containing E. histolytica 
cyst(8). In areas with low socio-economic 
conditions, there is a decrease in sanitation and an 
increase in faecal contamination from water 
supplies(4,8). Relatively better hygiene and 
sanitation in developed countries has a low 
incidence of amebiasis, which is 2-11%, whereas 
in Indonesia it has a quite high range ie 10-18%(9). 
 
Life cycle 
E. histolytica has a life cycle that can be 
divided into 2 phase, as an infectious cyst or 
invasive trophozoite(4). E. histolytica cysts can be 
discovered in contaminated food or water, after 
consumption occurs excystation, then trophozoites 
colonize the large intestine multiplying with binary 
fission. It can be asymptomatic or cause symptoms 
such as diarrhea. Trophozoites that attack the 
intestine produce amoebic colitis with ulceration 
which causes bloody diarrhea. Trophozoites can 
spread through the bloodstream and cause 
abscesses in some organs, which are most often 
observed or spread to farther places such as the 
brain and lungs in a hematogenous manner (Figure 
1). Within a few weeks after ingestion, symptoms 
can occur but sometimes can also develop for 
several years after infection(4,11). 
Figure 1. Life Cycle of E. Histolytica (14) 
MOLECUL SURFACE OF ENTAMOEBA 
CELL HISTOLYTICA 
Lipophosphopeptidoglycan and Other GPI-
Anchored Cell Surface Molecules 
On the trophozoite surface has 
lipophosphopeptidoglycans (LPPG), 
glycosylphosphatidylinositol (GPI) which contains 
complex carbohydrates and forms a glycocalyx 
layer. These molecules are the main surface 
components that interact with target cells, ie human 
tissue, via terminal sugar molecules(9). 
 
Gal/ Gal NAc Lectin Galactose/ N acetyl D-
galactosamine inhibitable (Gal/GalNAc) 
One of the main cell surface molecules 
associated with adherence to E. histolytica to the 
basement membrane and epithelial tissue. The 
Gal/GalNAc lectin consists of Heavy subunits 
(Hgl), Light subunits (Lgl) and Subunit 
intermediates (Igl). HgI and LgI are connected via 
disulfide bonds and live on the parasite cell 
membrane as a 260kDa heterodimer. HgI contains 
carbohydrate recognition domain (CRD) which 
recognizes d-galactose and N-acetyl-d-
galactosamine and host cell glycoconjugate 
proteins (3,12). 
 
SECRETED MOLECULES INVOLVED 
IN PATHOGENESIS 
Damage to the extracellular matrix, tissue, 
and cells is a characteristic pathophysiological of 
amoeba. Cell contact is the beginning of invasion 
of E. histolytica. Amoeba also attacks by reducing 
or damaging tissue by secreting several enzymes 
capable of digesting tissues or even extracellular 
matrices(12). 
 
Cysteine Proteases (CP) 
Entamoeba secretes Cysteine Proteases 
which are the main group of hydrolases. Genome 
helps identify about 50 genes that encode cysteine 
peptidase. Only 20 CP genes contained in E. 
histolytica are secreted, where EhCP1, EhCP2 and 
EhCP5 constitute 90% of all existing CP. CP can 
reduce extracellular matrix proteins (ECM) such as 
mucin which is the main component of colon 
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mucus. CP also attacks the immune system by 
reducing host antibodies. EhCP5 found on the 
surface of the amoeba suspected to interfere with 
mucin barrier of the colon. EhCP5 is also 
associated with colon epithelial cell integrins and 
activates the NFkappaβ-mediated inflammatory 
response in host cells. Research in 2014 showed 
that EhCPA5 activates matrix metalloproteinase 
(MMP) by splitting(12,13). 
 
Amoebapores 
Amoebapores is a group of pore-forming 
peptides that mediate the killing of cells by acting 
as secreted toxins. Amoebapores has 3 different 
types (a, b, and c) which structurally and 
functionally similar to NK-lysin membrane and 
granulysin permeabilization proteins produced by 
mammalian T cells(11,12). All amoebapores induce 
pore formation in synthetic liposomes. 
Amoebapores requires pH ~ 5.2 for pore-forming 
activities needed for activity on the host cell 
membrane (11). 
 
PATHOGENESIS 
The pathogenesis of E. histolytica can be 
classified into three, namely: host cell death, 
inflammation, and parasitic invasion. Trophozoit 
can kill host cells with several different 
mechanisms, ie induction of programmed cell 
death, phagocytosis, and trogocytosis(4). 
 
Programmed Cell Death 
The initial pathogenesis begins with 
adherence of parasites in the colonic mucous layer 
through the Gal / GalNAc lectin adhesion molecule 
(Figure 2).  
Figure 2. Sequential model of cell killing and 
phagocytosis by Entamoeba histolytica(3). 
Several other molecules involved in the 
pathogenesis of amebiasis, namely Amoebapores 
which destroy bacteria in the colon environment. 
CP is considered an important parasitic weapon to 
penetrate the epithelium and destroy the host 
extracellular matrix (ECM) component. Before 
adherence cells, trophozoites secrete immune 
modulators which stimulate epithelial cells to 
produce proinflammatory cytokine macrophage 
migration inhibitory factor (EhMIF). EhMIF 
induces inflammation resulting in increased 
production of matrix metalloproteinase (MMP)(13). 
In a current study, MMP was shown to be needed 
for the invasion of E. histolytica tissue. MMP 
rupture the extracellular matrix in the intestine to 
increase cell migration and is shown excessively in 
parasitic infections, such as amebiasis (4,13). 
 
Phagocytosis 
Calcium-binding protein 1 (EhCaBP1) and 
EhC2PK on the ligand are one of the early signs of 
phagocytosis. EhC2PK binds PS amoeba and 
attracts EhCaBP1 to cell membranes. EhCaBP1 
binds to F-actin which affects cell proliferation, 
fluid phase endocytosis, and phagocytosis. 
EhCaBP1 also attracts EhAK1 alpha kinase to 
phosphorylate directly G-actin. The interaction 
depends on calcium, while the interactions of 
EhC2PK and EhCaBP1 are not calcium dependent.  
Other calcium binding proteins such as EhCaBP3 
interact directly with lipids and function in the 
initiation of independent phagocytosis from the 
EhCaBP1/EhC2PK pathway. Whereas EhCaBP5, 
has recently been shown to interact with myosin 1B 
in an independent manner of calcium(11,12).  
 
Trogositosis 
After attaching to the host cell, E. histolytica 
trophozoite digests host cells with different "bites" 
called trogocytosis amoeba (Figure 3), which 
begins to occur within one minute of contact with 
the host cell. Host cells are still alive when the 
process starts, but eventually die which is 
characterized by loss of membrane integrity. After 
the host cell is killed, the consumption of the 
amoeba stops and the trophozoite is released from 
the dead host cell. Trogocytosis of amoeba involve 
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physiological temperature, amoeba actin 
rearrangement, Gal / GalNAc lectin, EhC2PK, and 
signaling-PI3K. Each protein has a role in 
phagocytosis and trogocytosis of E. histolytica 
(Figure 4). Cell death after amoeba trogocytosis 
can be caused by accumulated physical damage to 
bitten cells(11). 
Figure 3. Trogocytosis and Phagocytosis of 
Amebiasis (11) 
 
Figure 4. Amoeba molecules that play a role in 
trogocytosis and phagocytosis(11) 
 
IMUN RESPONSE 
E. histolytica has promoted several 
mechanisms to avoid immune responses and persist 
in hosts (Figures 5 & 6). When the amebic 
trophozoites attack the colon epithelium, it 
activates an immune response in human hosts. To 
survive in the host, it is necessary to fight the 
immune system and control the host environment. 
The mucous layer in the gastrointestinal tract 
mostly functions as a major physical barrier to 
intestinal pathogens. The secondary defense of 
intestinal immune response to E. histolytica 
infection is by secreting mucosal immunoglobulins 
(Ig). One of the most produced Ig by plasma cells 
is secretory IgA which functions to avoid 
pathogens from attaching and removing mucosal 
barriers. 
In the early stages of infection, intestinal 
epithelial cells (IECs) bind and identify the Gal/ 
Gal NAc lectin via a toll like receptor (TLR), which 
activates NFKB to produce inflammatory 
cytokines including IL-6, IL-1β, IL-8, IL-12, TNF-
α, and IFN-γ. IECs are the second defense barrier 
against pathogens after the mucosal layer and first 
defense of host cells to fight parasites, host cells 
secrete an arrangement of pathogen recognition 
receptors (PRRs), including TLRs. IFN-γ is 
involved in cleaning the infection, whereas IL-4 
and TNF-α are associated with disease(13). 
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Figure 5. Mechanism of colonization and 
invasion by E. histolytica trophozoites.(13) 
 
 
Figure 6. Mechanism of Avoiding Immune 
Response (13) 
 
THERAPY 
Patients diagnosed with amebiasis should be 
given medication. Patients with clinical symptoms 
should take treatment with 2 drugs: amebicidal 
tissue active agent, metronidazole or tinidazole and 
luminal cysticidal agent, paromomycin. Patients 
with asymptomatic amebiasis have need to be 
given luminal cysticidal agents to avoid invasion 
and transmission of pathogens(4). 
 
CONCLUSION 
The pathogenesis of amebiasis involves the 
interaction of several molecules secreted by E. 
histolytica such as lectin, LPPG, moebapore and 
cysteine proteases. Advances in molecular 
methodologies over the past few years have 
increased understanding of the mechanisms of 
amebiasis molecular pathogenesis such as 
adherence, phagocytosis and host cell 
tropogocytosis. Likewise the mechanism for 
avoiding cell immune responses such as IL-10 
induction and suppression of INF- γ, reduction of 
Ig, pro inflammatory cytokines, and complement. 
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